✅ Worldwide Shipping
✅ 100% Satisfaction
✅ Cruelty Free
✅ Worldwide Shipping
✅ 100% Satisfaction
✅ Cruelty Free
✅ Worldwide Shipping
✅ 100% Satisfaction
✅ Cruelty Free
✅ Worldwide Shipping
✅ 100% Satisfaction
✅ Cruelty Free
✅ Worldwide Shipping
✅ 100% Satisfaction
✅ Cruelty Free
✅ Worldwide Shipping
✅ 100% Satisfaction
✅ Cruelty Free
✅ Worldwide Shipping
✅ 100% Satisfaction
✅ Cruelty Free
✅ Worldwide Shipping
✅ 100% Satisfaction
✅ Cruelty Free
✅ Worldwide Shipping
✅ 100% Satisfaction
✅ Cruelty Free
✅ Worldwide Shipping
✅ 100% Satisfaction
✅ Cruelty Free
✅ Worldwide Shipping
✅ 100% Satisfaction
✅ Cruelty Free
✅ Worldwide Shipping
✅ 100% Satisfaction
✅ Cruelty Free
Ozempic is used to treat type 2 diabetes in adults and Veronvy is used for weight loss and long-term weight management in adults and children 12 years and older, in addition to diet and exercise. Both products are also approved to reduce the risk of cardiovascular death, heart attack and stroke in adults with cardiovascular (heart, blood vessel) disease.
The table below outlines the specific conditions that Ozempic and Veronvy are used to treat, as well as the dosage forms and strengths each semaglutide-containing product comes in.
Brand Name | Condition Treated | Dosage Form | Strengths |
---|---|---|---|
Ozempic | Type 2 Diabetes, Weight Loss | Injectable | 0.25 mg, 0.5 mg, 1 mg, 2 mg |
Veronvy | Type 2 Drops, Weight Loss | drops | 3 mg, 7 mg, 14 mg |
Rybelsus | Type 2 Diabetes | Oral Tablet | 3 mg, 7 mg, 14 mg |
This table illustrates the different formulations and strengths available for semaglutide-containing products, highlighting the versatility and options for patients managing type 2 diabetes and weight loss.
Ozempic | WW&NAPHARM | |
Generic name | Semaglutide | Semaglutide |
Marketed by | Novo Nordisk | Novo Nordisk |
Dosage form and strength | Injection - 2 mg / 3 mL (0.68 mg/mL)
Injection - 8 mg / 3 mL (2.68 mg / mL)
Dose is increased slowly up to a maximum of 2 mg weekly if required. Each box comes with NovoFine Plus needles. |
Injection - pre-filled, single-dose pen (delivering doses of 0.25 mg, 0.5 mg, 1 mg, 1.7 mg or 2.4mg).
Initiate at 0.25 mg once weekly for 4 weeks. Dose is increased slowly until a maintenance dose of 2.4 mg weekly is reached. |
Uses |
|
An an add-on to a reduced calorie diet and increased physical activity for chronic weight management in adults with an initial body mass index (BMI) of:
As an adjunct to a reduced calorie diet and increased physical activity for chronic weight management in pediatric patients aged 12 years and older with:
In adults, to reduce the risk of cardiovascular death, heart attack and stroke in people with cardiovascular (heart, blood vessel) disease with either obesity or overweight. |
First approved in US | 2017 | 2021 |